| +380 44 495-10-14 |
rus | eng
|
|
Dexapos eye dropsATC code: S 01 B A01
Active ingredient: Dexamethason-21-sulfobenzoate sodium
Indication:
Severe non-infections inflammation of the eye like severe allergics of the eye, severe conjunctivitis, keratitis, severe inflammations of the outerior part of the eye, postoperative irritations. Dosages: If not otherwise prescribed, instill 1 drop 3 to 5 times daily into the affected eye. Treatment with Dexapos eye drops should not normally extend beyond a period of 2 weeks, or maximally 3 weeks. The exact duration of Dexapos therapy should be based on the physician's judgement when all factors including efficacy, severity of symptoms, and potential side-effects are considered. ADVANTAGES: quick and long lasting anti-inflammatory activity one of the most potent corticosteroid available for ophthalmological therapy prolonged action due to the addition of methyl hydroxypropyl cellulose excellent tolerance guaranteed by physiologic pH manufactured according to GMP- and PIC-standards, Certificated according to DIN 9001:2000, ISO 1 Stability: With proper care Dexapos eye drops can be used up to 4 weeks after the bottle has been opened. Dexapos should not be stored above 25 C. The duration of stability is 3 years. Dexapos should not be used beyond the expiration date (imprinted on the packaging carton). Packaging: 10 ml bottle. For production reasons the bottle is only half filled, but will contain a 5 ml measured amount Dexapos eye drop solution. |
29.05.2010
21.05.2010
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sona-Pharm LLC
Ukraine, 03680 Kyiv Mykoly Grinchenka Str., 4 Теl: +38 044 495 10 14 Fax: +38 044 495 10 15 office@sona-pharm.com.ua |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||